Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1. | Int J Mol Sci | 2024 | 38791252 | PubTator, text mining | PubMed |
| Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway. | Mol Med | 2024 | 38760717 | PubTator, text mining | PubMed |
| Junctional Epidermolysis Bullosa Linked to Homozygous Mutation in LAMC2 Gene: A Case Report With Eosinophil-Rich Inflammatory Infiltrate. | Am J Dermatopathol | 2024 | 38648026 | PubTator, text mining | PubMed |
| Ribonucleic Acid Sequencing Reveals the Upregulation and Resolution of Inflammation and Extracellular Matrix Remodeling in Lidocaine-Treated Human Acute Monocytic Leukemia Cell Line THP-1. | Biomedicines | 2024 | 38540122 | PubTator, text mining | PubMed |
| Oncogenic Roles of Laminin Subunit Gamma-2 in Intrahepatic Cholangiocarcinoma via Promoting EGFR Translation. | Adv Sci (Weinh) | 2024 | 38526177 | PubTator, text mining | PubMed |
| CSF or middle ear effusion? Diagnostical dilemmas in a patient with temporal bone meningioma: A case report. | Heliyon | 2024 | 38524529 | PubTator, text mining | PubMed |
| YAP/TAZ-mediated regulation of laminin 332 is enabled by β4 integrin repression of ZEB1 to promote ferroptosis resistance. | J Biol Chem | 2024 | 38508310 | PubTator, text mining | PubMed |
| Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer. | Cell Rep | 2024 | 38446659 | PubTator, text mining | PubMed |
| Observing Dynamic Conformational Changes within the Coiled-Coil Domain of Different Laminin Isoforms Using High-Speed Atomic Force Microscopy. | Int J Mol Sci | 2024 | 38396630 | PubTator, text mining | PubMed |
| Phenotypic differences in intermediate generalized junctional epidermolysis bullosa with homozygous LAMC2 mutation and a potential genetic modifier. | J Eur Acad Dermatol Venereol | 2024 | 38376117 | PubTator, text mining | PubMed |
| Endothelium-specific deletion of p62 causes organ fibrosis and cardiac dysfunction. | J Transl Med | 2024 | 38365674 | PubTator, text mining | PubMed |
| Heterogeneous DNA hydrogel loaded with Apt02 modified tetrahedral framework nucleic acid accelerated critical-size bone defect repair. | Bioact Mater | 2024 | 38298451 | PubTator, text mining | PubMed |
| En Route to Targeted Ribosome Editing to Replenish Skin Anchor Protein LAMB3 in Junctional Epidermolysis Bullosa. | JID Innov | 2024 | 38282649 | PubTator, text mining | PubMed |
| Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets. | Cell Commun Signal | 2024 | 38279122 | PubTator, text mining | PubMed |
| Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling. | Sci Rep | 2024 | 38267509 | PubTator, text mining | PubMed |
| Single-cell landscape of the cellular microenvironment in three different colonic polyp subtypes in children. | Clin Transl Med | 2024 | 38264936 | PubTator, text mining | PubMed |
| RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer. | Biomedicines | 2024 | 38255305 | PubTator, text mining | PubMed |
| Transforming growth factor-induced gene TGFBI is correlated with the prognosis and immune infiltrations of breast cancer. | World J Surg Oncol | 2024 | 38245723 | PubTator, text mining | PubMed |
| 3'-Sialyllactose alleviates bone loss by regulating bone homeostasis. | Commun Biol | 2024 | 38243116 | PubTator, text mining | PubMed |
| Emerging roles of exosomes in oral diseases progression. | Int J Oral Sci | 2024 | 38221571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=7